Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents
| Autor: | M. M. Samama, J. Horrow, O. Taby, C. M. Samama, W. Dietrich |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
medicine.medical_specialty
Antifibrinolytic Blood transfusion medicine.drug_class business.industry medicine.medical_treatment medicine.disease Hyperfibrinolysis Surgery Antifibrinolytic agent medicine Thrombolytic Agent Aprotinin Aminocaproic acid Intensive care medicine business Tranexamic acid medicine.drug |
| Zdroj: | Handbook of Experimental Pharmacology ISBN: 9783642630293 |
| DOI: | 10.1007/978-3-642-56637-0_21 |
| Popis: | Antifibrinolytic therapy constitutes an effective means to control or reduce bleeding and to limit or avoid blood transfusion in current medical practice. During the past 30 years it has been used as an established antidote in patients treated by thrombolytic agents and experiencing bleeding complications. Antifibrinolytic drugs have also been prescribed in patients developing clinical hyperfibrinolysis. However, use of these products has been limited to very specific situations involving small numbers of patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|